Paul Jurewicz

PE-sponsored Behavioral Health Services Provider: As Chief Financial Officer, Paul led efforts to comprehend and maximize the payer mix resulting in 20% same store growth. He achieved 100% year over year growth in EBITDA driven by sales growth and cost control. Paul led efforts to resolve acquisition related litigation. He also implemented companywide practice management and billing software, resulting in significant DSO reduction and improved cash collection with cash collections increasing from $1.0 million to $1.5 million per month. Paul chaired the Company’s Compliance Committee and directed the Company’s I/T and facilities maintenance functions. He completed the Company’s audit for two years post-settlement of the acquisition related litigation. 

Provider of Services for Individuals with Intellectual and Developmental Disabilities: As Chief Financial Officer, Paul led planning and reporting functions for this $5 million not-for-profit agency. He managed outsourced information technology and facilities maintenance functions. Paul led revenue cycle activities including governmental payers maintaining a DSO of less than 40. He also served as the Company liaison to the Finance Committee of the Board of Directors. 

Reference Laboratory, Subsidiary of Mayo Clinic: As CFO and CAO, Paul enhanced the organization’s sales strategy resulting in 18% organic growth and sales levels nearing $300 million while improving operating margins to $40 million. He discontinued two service lines improving profitability by $3 million. Paul co-sponsored the implementation of a new information technology platform designed to reduce costs while improving customer service and Paul Jurewicz Partner quality. A 15-20% sales growth caused the need for expanded space and improved processes, Paul co-managed the successful completion of a move to new facilities and the implementation of lean, six-sigma, and best practices that resulted in +20% profit growth. He also revamped internal financial reporting to increase visibility to service line profitability and financial metrics. Paul implemented new costing procedures to refine product gross profit. 

Medical Device Manufacturer and Distributor: As Chief Financial Officer, Paul directed treasury, financial reporting, investor relations, customer service, IT, and manufacturing operations in a VC-backed environment. Within 3 months of starting with the company, Paul recommended a complete revamping of sales strategy to address slow growth leading to repositioned product lines and a redefined and overhauled sales team. Paul also developed OEM partnerships and GPO contracts. Under his leadership, revenue over 3 years went from $1.2 to $2.5 to $6MM and the company ultimately sold for $166MM. He also raised over $10 million in preferred equity financing. Rapid volume increases created numerous complexities in the complete outsourcing of the manufacturing of the product, including limited sales history on which to base future manufacturing requirements. Paul managed the full range of production, including numerous component suppliers and foreign assembly. He successfully supported growing product demand, including working through the challenges of post-9/11 border controls.